30th March 2020 - *IMPORTANT UPDATE* - We have now completed a risk assessment for the safe-handling of potential and known positive COVID-19 samples in our laboratory. We can now undertake clozapine plasma testing in such patients, which we know might be useful given the respiratory symptoms and the possible effect this may have for patients who smoke. Although we continue to treat all samples as potentially infectious, please ensure that when sending such samples the request form is clearly marked if the patient has tested positive for COVID-19. It is also imperative that samples are packaged appropriately using the kits provided, including the rigid tube and absorbent materials that are supplied, since these comply with UN3373 Category B requirements.
26th March 2020 - *NEW - IMPORTANT* - Please note that ASI is not a Containment Level III laboratory. As such, we cannot process any samples from suspected/known COVID-19 positive patients at present. We have sought advice on how to proceed in cases where a clozapine plasma level is absolutely required, and will update you as soon as we have any further information, but until such time please do not send samples from suspected or confirmed COVID-19 positive patients. Please contact the laboratory for any further information, or if you have any questions. Many thanks.
24th March 2020 - *NEW* - For all registered users – please note that we are launching an updated version of this portal, incorporating a number of small improvements based on your feedback. The new-look portal will be launched on Monday 6th April 2020. All the current functionality remains, plus the new-look portal should be simpler to navigate, and it should be simpler to find specific patient results by searching results by sample location. In addition, there are new request forms available for download for non-clozapine antipsychotic drug testing. A new ‘how-to’ video will be available to help if required. Our contact information remains unchanged should you have any questions regarding the new site, or should you face any problems when the new site is launched.
7th February 2020 - Reacting to customer feedback and confusion about alerting results by e mail, the use of ‘Pending’ in the results section has now been discontinued. This has been done to simplify the process for each user – and we hope you see the improvement. If you have any queries, please contact our Hotline: 020 8725 2845.
7th February 2020 - We are pleased to report that technical instrumentation difficulties have been resolved and the Clozapine service resumes as normal. Apologies for any inconvenience caused.
31st January 2020 - We are currently experiencing instrumentation downtime which may delay results being uploaded to the portal. We are working to resolve these problems as soon as possible to resume normal service, and apologise for any delays. Please contact the laboratory should you have any questions regarding specific sample results.
20th August 2019 - We have now rectified the issue of 'pending' results (see the notice from 1st August 2019) which related to our database updates. Now, if you see 'Pending' in the Results table, this means the sample has been safely received in the laboratory and logged on to our system, and is currently undergoing analysis. The results will be updated and available to view once they have been authorised by our scientists.
16th August 2019 - You can now download and save/print .PDF copies of clozapine assay reports directly from the Portal. Simply click the 'Results Sheet' icon in your results table, and the .PDF will open in a new window/tab.
1st August 2019 – If you log-in to view results and they appear ‘Pending’, the most likely explanation is that we are in the process of updating the database with new data. This usually takes about 15-20 minutes with the require encryption, so please re-try logging in after this period. If you are still unable to see specific results, please do call us for any urgent cases using the hotline 020 8725 2405. We try to carry out the updates early in the morning where possible to avoid disruption, and we have a solution to further minimise the time taken to update the database which will be implemented shortly, after we have completed testing.
12th June 2019 – Please note, ASI do not supply sampling kits for plasma levels. These are available through your relevant clozapine monitoring services, pre-addressed with the laboratory address.
11th June 2019 – Please ensure that request forms are fully completed, and samples fully labelled. We are unable to analyse samples where the sample tube and request form cannot be matched with at least three identifiers.